Skip to main content
. 2021 Nov 10;375:e066534. doi: 10.1136/bmj-2021-066534

Table 1.

Baseline characteristics of study patients overall and stratified by patients receiving epinephrine (adrenaline) first and defibrillation first

Variable Overall (n=34 820) Epinephrine first (n=7054) Defibrillation first (n=27 766) Standardized difference
Personal characteristics:
 Age (years):
  Mean (SD) 65.8 (14.4) 65.6 (15.0) 65.9 (14.3) 2.3
  Median (IQR) 67 (57-77) 67 (57-77) 67 (57-77)
 Sex: −1.9
  Male 22 039 (63.3) 4412 (62.5) 17 627 (63.5)
  Female 12 781 (36.7) 2642 (37.5) 10 139 (36.5)
Race
 White 26 531 (76.2) 5093 (72.2) 21 438 (77.2) −11.5
 Black 4972 (14.3) 1274 (18.1) 3698 (13.3) 13.1
 Other 3317 (9.5) 687 (9.7) 2630 (9.5) 0.1
 Hispanic ethnic origin 1597 (4.6) 412 (5.8) 1185 (4.3) 7.2
Pre-existing conditions
 Myocardial infarction, this admission 9725 (27.9) 1390 (19.7) 8335 (30.0) −24.0
 Myocardial infarction, previous admission 7947 (22.8) 1393 (19.7) 6554 (23.6) −9.4
 Congestive heart failure, this admission 7642 (21.9) 1415 (20.1) 6227 (22.4) −5.8
 Congestive heart failure, previous admission 9095 (26.1) 1806 (25.6) 7289 (26.3) −1.5
 Diabetes mellitus 11 432 (32.8) 2470 (35.0) 8962 (32.3) 5.8
 Renal insufficiency 10 753 (30.9) 2610 (37.0) 8143 (29.3) 16.4
 Hepatic insufficiency 2055 (5.9) 485 (6.9) 1570 (5.7) 5.0
 Respiratory insufficiency 12 292 (35.3) 2894 (41.0) 9398 (33.8) 14.9
 Pneumonia 3482 (10.0) 838 (11.9) 2644 (9.5) 7.6
 Sepsis/septicemia 4021 (11.5) 1108 (15.7) 2913 (10.5) 15.5
 Hypotension/hypoperfusion 7991 (22.9) 1791 (25.4) 6200 (22.3) 7.2
 Acute stroke 1265 (3.6) 287 (4.1) 978 (3.5) 2.9
 Acute CNS event non-stroke 1865 (5.4) 407 (5.8) 1458 (5.3) 2.3
 Baseline CNS depression 2742 (7.9) 597 (8.5) 2145 (7.7) 2.7
 Major trauma 886 (2.5) 267 (3.8) 619 (2.2) 9.1
 Metastatic/hematologic malignancy 2814 (8.1) 727 (10.3) 2087 (7.5) 9.8
 Metabolic/electrolyte abnormalities 5428 (15.6) 1285 (18.2) 4143 (14.9) 8.9
Cardiac arrest characteristics
Initial cardiac rhythm −6.3
 Pulseless ventricular fibrillation 21 539 (61.9) 4237 (60.1) 17 302 (62.3)
 Pulseless ventricular tachycardia 13 281 (38.1) 2817 (39.9) 10 464 (37.7)
Time to first defibrillation (min)
 0 to <2 22 288 (64.0) 1376 (19.5) 20 912 (75.3) −134.8
 >2 to 4 6042 (17.4) 1780 (25.2) 4262 (15.4) −113.7
 >4 6490 (18.6) 3898 (55.3) 2592 (9.3) 112.7
Location of arrest:
 Intensive care unit 19 094 (54.8) 3956 (56.1) 15 138 (54.5) 3.1
 Operating room/procedural area 4144 (11.9) 709 (10.1) 3435 (12.4) −7.4
 Inpatient ward with telemetry 7121 (20.5) 1276 (18.1) 5845 (21.1) −7.5
 Inpatient ward without telemetry 3969 (11.4) 1026 (14.5) 2943 (10.6) 11.9
 Other 492 (1.4) 87 (1.2) 405 (1.5) −2.0
Activation of hospital-wide response 27 283 (78.4) 5532 (78.4) 21 751 (78.3) 0.2
Night-time arrest (11 pm to 7 am) 10 219 (29.4) 2233 (31.7) 7986 (28.8) 6.3
Interventions in place at the time of arrest:
 Assisted or mechanical ventilation 12 727 (36.6) 2935 (41.6) 9792 (35.3) 13.1
 Antiarrhythmic agent 2771 (8.0) 325 (4.6) 2446 (8.8) −16.9
 Dialysis or extracorporeal treatments 1195 (3.4) 300 (4.3) 895 (3.2) 5.4
 Vasoactive agent 9397 (27.0) 2028 (28.7) 7369 (26.5) 4.5
Calendar year of arrest:
2000-05 9871 (28.3) 1481 (21.0) 8390 (30.2) −21.2
2006-10 9009 (25.9) 1791 (25.4) 7218 (26.0) −1.4
2011-15 9252 (26.6) 2158 (30.6) 7094 (25.6) 11.2
2016-18 6688 (19.2) 1624 (23.0) 5064 (18.2) 11.8

CNS=central nervous system; IQR=interquartile range; SD=standard deviation.